100 medicines held by Merck Sharp & Dohme BV on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Noxafil 300 mg gastro-resistant powder for oral suspension EU/1/05/320/005 |
Posaconazole | Merck Sharp & Dohme BV, | — |
| Noxafil 40 mg/ml oral suspension EU/1/05/320/001 |
Posaconazole | Merck Sharp & Dohme BV, | — |
| Pifeltro 100 mg film-coated tablets EU/1/18/1332/001-002 |
Doravirine | Merck Sharp & Dohme BV, | — |
| PREVYMIS 240 mg Concentrate for solution for infusion EU/1/17/1245/003 |
LETERMOVIR | Merck Sharp & Dohme BV | — |
| PREVYMIS 240 mg Film-coated tablet EU/1/17/1245/001 |
LETERMOVIR | Merck Sharp & Dohme BV, | — |
| PREVYMIS 480 mg Concentrate for solution for infusion EU/1/17/1245/004 |
LETERMOVIR | Merck Sharp & Dohme BV | — |
| PREVYMIS 480 mg Film-coated tablet Oral use EU/1/17/1245/002 |
LETERMOVIR | Merck Sharp & Dohme BV | — |
| ProQuad powder and solvent for suspension for injection EU/1/05/323/1-13 |
Mumps virus live attenuated jeryl lynn strain, Rubella virus (wistar ra 27/3 strain) live attenuated, Varicella virus vaccine live (oka/merck) | Merck Sharp & Dohme BV, | — |
| Recarbrio 500 mg/500 mg/250 mg powder for solution for infusion EU/1/19/1420/001 |
Imipenem, Cilastatin, Relebactam | Merck Sharp & Dohme BV, | — |
| Ristaben 100 mg film-coated tablets EU/1/10/621/13-18 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV, | — |
| Ristaben 25 mg film-coated tablets EU/1/10/621/1-6 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV | — |
| Ristaben 50 mg film-coated tablets EU/1/10/621/7-12 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV, | — |
| Ristfor 50 mg/1000 mg film-coated tablets EU/1/10/620/009-016 |
Metformin Hydrochloride, Sitagliptin phosphate | Merck Sharp & Dohme BV, | — |
| Ristfor 50 mg/850 mg film-coated tablets EU/1/10/620/1-8 |
Metformin Hydrochloride, Sitagliptin phosphate | Merck Sharp & Dohme BV | — |
| RotaTeq oral solution Rotavirus vaccine (live) EU/1/06/348/01 |
Rotavirus vaccine, live, pentavalent gi, Rotavirus vaccine, live, pentavalent g2, Rotavirus vaccine, live, pentavalent g3, Rotavirus vaccine, live, pentavalent g4, Rotavirus vaccine, live, pentavalent p1 | Merck Sharp & Dohme BV, | — |
| Segluromet 2.5 mg/1 000 mg film-coated tablets EU/1/18/1265/008-014 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Segluromet 2.5 mg/850 mg film-coated tablets EU/1/18/1265/001-007 |
Metformin Hydrochloride, Ertugliflozin l-pyroglutamic acid | Merck Sharp & Dohme BV | — |
| Segluromet 7.5 mg/1 000 mg film-coated tablets EU/1/18/1265/022-028 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Segluromet 7.5 mg/850 mg film-coated tablets EU/1/18/1265/015-021 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Sivextro 200 mg film-coated tablets EU/1/15/991/001 |
Tedizolid phosphate | Merck Sharp & Dohme BV | — |
| Sivextro 200 mg powder for concentrate for solution for infusion EU/1/15/991/002-003 |
Tedizolid phosphate | Merck Sharp & Dohme BV | — |
| Steglatro 15 mg film-coated tablets EU/1/18/1267/007-012 |
Ertugliflozin l-pyroglutamic acid | Merck Sharp & Dohme BV | — |
| Steglatro 5 mg film-coated tablets EU/1/18/1267/001-006 |
Ertugliflozin l-pyroglutamic acid | Merck Sharp & Dohme BV | — |
| Steglujan 15 mg/100 mg film-coated tablets EU/1/18/1266/007-012 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Steglujan 5 mg/100 mg film-coated tablets EU/1/18/1266/001-006 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Stocrin EU/1/99/111/003 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| Stocrin EU/1/99/111/004 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| STOCRIN EU/1/99/111/001 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| STOCRIN EU/1/99/111/002 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| STOCRIN 200 mg film-coated tablets EU/1/99/111/011 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| STOCRIN 30 mg/mL oral solution EU/1/99/111/005 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| STOCRIN 50 mg film-coated tablets EU/1/99/111/010 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| Stocrin Film-Coated EU/1/99/111/6-7 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| Stocrin Film-Coated EU/1/99/111/8-9 |
Efavirenz | Merck Sharp & Dohme BV, | — |
| Temodal 2.5 mg/ml powder for solution for infusion EU/1/98/096/023 |
Temozolomide | Merck Sharp & Dohme BV | — |
| Tesavel 100 mg film-coated tablets EU/1/07/435/13-18 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV | — |
| Tesavel 25 mg film-coated tablets EU/1/07/435/1-6 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV, | — |
| Tesavel 50 mg film-coated tablets EU/1/07/435/7-12 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV | — |
| Vaxneuvance suspension for injection in pre-filled syringe EU/1/21/1591/001-006 |
Pneumococcal Polysaccharide Serotype 1 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 4 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 5 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197 | Merck Sharp & Dohme BV, | — |
| Velmetia 50 mg/1000 mg film-coated tablets EU/1/08/456/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Velmetia 50 mg/850 mg film-coated tablets EU/1/08/456/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV, | — |
| WELIREG 40 mg film-coated tablets EU/1/24/1893/001-002 |
Belzutifan | Merck Sharp & Dohme BV, | — |
| Winrevair 45 mg powder and solvent for solution for injection EU/1/24/1850/001-002 |
Sotatercept | Merck Sharp & Dohme BV, | — |
| Winrevair 60 mg powder and solvent for solution for injection EU/1/24/1850/003-004 |
Sotatercept | Merck Sharp & Dohme BV, | — |
| Xelevia 100 mg film-coated tablets EU/1/07/382/13-18 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Xelevia 25 mg film-coated tablets EU/1/07/382/1-6 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Xelevia 50 mg film-coated tablets EU/1/07/382/7-12 |
Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| ZEPATIER 50 mg/100 mg film-coated tablets EU/1/16/1119/001 |
Grazoprevir, Elbasvir | Merck Sharp & Dohme BV, | — |
| Zerbaxa 1 g/0.5 g powder for concentrate for solution for infusion EU/1/15/1032/001 |
Ceftolozane sulfate, Tazobactam sodium | Merck Sharp & Dohme BV, | — |
| ZINPLAVA 25 mg/mL concentrate for solution for infusion EU/1/16/1156/001 |
Bezlotoxumab | Merck Sharp & Dohme BV | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.